MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials

New research provides evidence that a single dose of psilocybin can boost brain connections

The Top 10 Psychedelic Research Papers of the Last 10 Years

Previous antidepressant use may blunt the effectiveness of MDMA-assisted psychotherapy for PTSD

LSD alters consciousness by breaking down barriers in the brain

Combining therapy with the psychedelic drug psilocybin results in large reductions in anxiety and depression

MDMA Could Be Tailored to Make It More Suitable for Treating Mental Illness

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo

An Amazonian tea stimulates the formation of new neurons

People who microdose psychedelic drugs report that the benefits greatly outweigh the drawbacks

A single dose of 5-MeO-DMT produces rapid and persistent improvements in life satisfaction and psychopathological symptoms

Neuroscientists uncover how magic mushrooms “rebalance” the brain

Therapeutic potential of ayahuasca in grief: a prospective, observational study

Scientists find magic mushrooms could help fight fascism

New research confirms lingering mood benefit of psychedelics

Psychedelic spurs growth of neural connections lost in depression

How meditation and psychedelic drugs could fix tribalism

A woman took 550 times the usual dose of LSD, with surprisingly positive consequences

First-of-its-kind study pits psilocybin against a common antidepressant

Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers

Psilocybin Causes ‘Significant Reduction’ in Symptoms of Depression, Largest of its Kind Study Shows